Cat.#: ACPP-1534
| Despition | RLN3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
| ACPP-1323 | FYN Blocking Peptide (AC1323) | 250 µg | inquiry |
| ACPP-1474 | Human RGS21 Protein (AC1474) | 5 µg | inquiry |
| ACPP-1689 | Human DUSP26 Protein (AC1689) | 5 µg | inquiry |
| ACPP-1255 | MC3 Receptor Blocking Peptide (AC1255) | 250 µg | inquiry |
| ACPP-1037 | Recombinant Human Robo1 Protein (Fc Tag) (AC1037) | 50 µg | inquiry |
| ACPP-1572 | Human AIF1 Protein (AC1572) | 2 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1747 | Human TSG Protein (AC1747) | 10 µg | inquiry |
| ACPP-1386 | Human HMGN1 Protein (AC1386) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.